Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research

Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research

New-onset diabetes (NOD) has emerged as a potential early indicator of pancreatic cancer (PC), necessitating a refined clinical approach for risk assessment and early detection. This study discusses critical gaps in understanding the NOD-PC relationship and proposes a multifaceted approach to enhanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Russell Moreland, Abigail Arredondo, Anupam Dhasmana, Swati Dhasmana, Shabia Shabir, Asfia Siddiqua, Bonny Banerjee, Murali M. Yallapu, Stephen W. Behrman, Subhash C. Chauhan, Sheema Khan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
pancreatic cancer
new-onset diabetes
screening strategies
biomarker discovery
socio-economic factors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1543112/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1543112/full

Similar Items